Article

Effect of treatment choices for cervical adenocarcinoma in situ on rates of residual disease, recurrence and progression

DOI: 10.1080/20742835.2017.1402434
Author(s): Johanna TheuwsRadboud University, The Netherlands, David G. AllenDepartment of Gynecologic Oncology, Australia

Abstract

Background: Cervical adenocarcinoma in situ (AIS) is the known precursor condition of cervical adenocarcinoma. The aim of this study is to evaluate treatment choices for AIS in terms of residual disease, recurrence and progression to invasive cancer.

Get new issue alerts for Southern African Journal of Gynaecological Oncology